Antiphospholipid syndrome
DOI:
https://doi.org/10.31053/1853.0605.v68.n2.21534Keywords:
antiphospholipid syndromeAbstract
Since the first detailed description of antiphospholipid syndrome (PAS) by Dr. Graham Hughes, this condition is today one of the most frequent autoimmune diseases. The impact of this description has been enormous, as the recognition of individuals with connective tissue diseases requiring anticoagulation instead of steroid treatment or with non-steroidal anti-inflammatory drugs has led to a fundamental change in medical practice.
Downloads
References
Hughes GRV. Trombosis, abortion, cerebral disease and lupus anticoagulant. Br Med J 1983; 287:1088-1089.
Hughes GRV. The antiphospholipid syndrome: ten years on. The Lancet 1993,342:341-4.
Wilson WA, Gharavi AE, Koike T et al. International Consensus Statement on preliminary classification criteria for definitive Antiphospholipid Síndrome.Report of an international workshop. Arthritis Rheum 1999;42:1309-1311.
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al. International Consensus statement on an update of the clasification criteria for definitive antiphospholipid syndrome. J Thromb Haemost 2006; 4 : 295-306.
Ruiz-Irastorza G, Crowther M, Khamashta MA. Antiphospholipid syndrome. The Lancet 2010;376:1498-1509.
Cervera R, Piette JC, Font J et al. Antiphospholipid syndrome: Clinical and immunological manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002;46: 1019-1027.
Cervera R, Asherson RA. Síndrome Antifosfolìpidico:nuevas perspectivas clìnicas y terapeùticas. Reumatol Clin 2005 ;1:183-6.
Giannakopoulus , Pasma F, Ioannou Y, Krillis SA. How we diagnose the antiphospholipid syndrome. Blood 2009;114: 2020-30.
Downloads
Published
How to Cite
Issue
Section
License
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).